Pharma Reviews: Nearly 50% Indian pharma cos under pressure to opt out of US market over DSCSA mandate

Even as the November 2017 deadline for implementation of second phase of US Drug Supply Chain Security Act (DSCSA) is approaching fast, ...
Read more: Nearly 50% Indian pharma cos under pressure to opt out of US market over DSCSA mandate